https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

The immunopathology unit of IDIVAL delves into the effectiveness of certain treatments for patients with giant cell arteritis

19 de July de 2024

Two new publications show results on the effectiveness of inhibitors of janus kinases (iJAK) in giant cell arteritis (GCA) and on the effectiveness of the antibody tocilizumab for aortitis in GCA. Researchers from the Immunopathology Group of IDIVAL, led by Dr. Javier Loricera García and Dr. Ricardo Blanco Alonso, have carried out two studies to […]

Read more →

IDIVAL Nursing research group presents advances of the JACARDI project in the fight against cardiovascular diseases and diabetes

17 de July de 2024

The meeting of the IDIVAL Nursing research group highlighted the progress and next steps in the pilots it is leading in Cantabria on health literacy, integrated care pathways and self-management of patients with these diseases. On July 2, the Nursing research group of the Marqués de Valdecilla Health Research Institute (IDIVAL), led by Dr. Carmen […]

Read more →

Valdecilla Clinical Trials Unit and IDIVAL Research Support Unit highlight the crucial role of talent in clinical trials

3 de June de 2024

The Valdecilla Clinical Trials Unit and the Research Support Unit of the Marqués de Valdecilla Research Institute (IDIVAL) have highlighted the importance of specialised talent in supporting the execution of clinical trials. This announcement comes in light of recent findings published in a comprehensive review on challenges and solutions in the field of clinical trials. […]

Read more →

Next seminar at IDIVAL given by Dr. Young J. Juhn, from the Mayo Clinic, on the social determinants that affect health

Next Wednesday, June 5, Dr. Young J. Juhn will visit IDIVAL with the aim of establishing a collaboration with Cohorte Cantabria. Dr. Young J. Juhn is Professor of Pediatrics and Clinical Investigator at the Mayo Clinic. He is currently the Chair of Research at Mayo Clinic Health System and Director of the Artificial Intelligence Program […]

Read more →

IDIVAL researchers will coordinate the 3rd Northern Headache Meeting on 7th and 8th June

23 de May de 2024

Speakers who are experts in the field of headaches will discuss the latest advances in their diagnosis and treatment Headaches, characterised by recurrent headaches, are one of the most common disorders of the nervous system, affecting people of all ages, races, income levels and geographical areas.  It is not only painful but also disabling, as […]

Read more →

IDIVAL organizes a round table focused on the use of artificial intelligence in the health care environment

10 de May de 2024

The event will take place on May 21 at IDIVAL’s facilities The Marqués de Valdecilla Health Research Institute (IDIVAL) is organizing a round table discussion entitled “Artificial intelligence: how can we use it in the healthcare environment” on May 21. The initiative will take place in person at the IDIVAL headquarters at 13:30h and will […]

Read more →

IDIVAL evaluates the activity of its research groups in its External Scientific Council

6 de May de 2024

This advisory body meets regularly and ensures the scientific quality of the institute. The members of the External Scientific Council of the Marqués de Valdecilla Health Research Institute (IDIVAL) met last week at IDIVAL and online in order to evaluate the activity of some research groups of the center, as well as to monitor the […]

Read more →

Single-parent families have lower incomes, poorer physical health or weaker supportive relationships according to a study by IDIVAL’s Health Economics Group

30 de April de 2024

The conclusions obtained in the research could help design policies to address the difficulties of this type of families. A recent study published in the international Journal of Family and Economic Issues by the Health Economics Group of the Marqués de Valdecilla Health Research Institute (IDIVAL) explored economic circumstances, lifestyle factors (obesity, smoking and alcohol) […]

Read more →

Cantabria joins the European FAITHFUL project for early detection of heart failure with artificial intelligence

23 de April de 2024

1.7 million, the project will run until the end of 2025 and will involve leading international institutions in the sector.  The FAITHFUL,  innovation project consortium, led by the Spanish startup Idoven, thanks to the support of EIT Health, has just launched the development of a technological solution that aims to prevent 4 out of 10 […]

Read more →

Santander will host the first international symposium on rare liver diseases

3 de April de 2024

IDIVAL researcher Javier Crespo is coordinating the congress, which will take place on 11th and 12th April The 1st International Symposium on Rare Liver Diseases 2024 will bring together leading national and international experts in the field of rare liver diseases, with the aim of sharing knowledge, scientific advances and clinical experiences relevant to the […]

Read more →